Costa Michael Lourenco 4

What Happened

• Costa Michael Lourenco, Executive Vice President, Chief Financial Officer & Treasurer of Sabra Health Care REIT (SBRA), was credited with 4,200 stock units on 2026-05-29 as an award/grant (transaction code A). The units were recorded at $0.00 (no cash purchase). These units are dividend-equivalent payments tied to previously granted stock units and will vest and be payable on the same terms as the original awards.

Key Details

• Transaction date: 2026-05-29; reported acquisition type: Award/Grant (code A); acquisition price reported: $0.00.
• Form filed: 2026-06-02 (filed within the SEC Form 4 deadline — timely).
• Shares/units called out in filing: the filing notes these are dividend-equivalent stock units (F1) and that the reporting person’s holdings include 282,615 stock units that, upon settlement, will be paid one-for-one in common shares (F2).
• No cash changed hands for this credit; this is compensation-related, not an open-market purchase or sale.

Context

• These units are dividend equivalents credited on previously granted equity awards and will vest/pay out under the same schedule as those original awards — a routine compensation action rather than a direct bullish or bearish trading signal.
• For retail investors: awards and dividend-equivalent credits indicate executive compensation and potential future dilution when units settle into shares, but they do not by themselves indicate insider buying or selling intent.